Artemis Medicare Services Holds 22nd AGM; Approves Dividend & Director Re-appointments
Artemis Medicare Services Limited held its 22nd AGM on July 31, 2026. Shareholders approved the financial statements for FY26 and declared a dividend of Re. 0.45 per share. Ms. Shalini Kanwar Chand was re-appointed as Director. M/s. T R Chadha & Co LLP re-appointed as Statutory Auditors. Mr. Tapan Mitra and Dr. Girdhar Gyani appointed as Independent Directors.
The AGM involved routine corporate actions like dividend declaration and director re-appointments, which are important for governance but do not represent a significant strategic shift or financial event that would have a high immediate impact.
The AGM proceedings were smooth, with approval of financial statements, dividend declaration, and re-appointments, indicating positive corporate governance and operational continuity.
Artemis Medicare Services Limited held its 22nd Annual General Meeting (AGM) on July 31, 2026, via Video Conferencing. The meeting, chaired by Mr. Onkar Kanwar, commenced at 3:00 P.M. IST and concluded at 3:25 P.M. IST.
The shareholders approved the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, along with the respective Board and Auditors' reports. A final dividend of Re. 0.45 per equity share (45%) for the financial year ended March 31, 2026, was declared, payable to shareholders on record as of July 10, 2026.
Key appointments and re-appointments were also approved. Ms. Shalini Kanwar Chand was re-appointed as a Director liable to retire by rotation. M/s. T R Chadha & Co LLP were re-appointed as Statutory Auditors for a second term of five years, until the conclusion of the 27th AGM in 2031. Mr. Tapan Mitra was appointed as an Independent Director for a term of three years from May 8, 2026, to May 7, 2029. Dr. Girdhar Jessaram Gyani was appointed as an Independent Director for a term of three years from August 1, 2026, to July 31, 2029. The payment of remuneration to Cost Auditors for FY 2026-27 and remuneration by way of commission to Non-Executive Directors were also ratified.
Shareholders had the opportunity to vote remotely from July 28, 2026, to July 30, 2026. Those present at the meeting who had not voted remotely were provided with an e-voting platform. The results of the voting were to be declared by the Company Secretary within the stipulated time.
What to do with a filing like this
Artemis Medicare Services Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Artemis Medicare Services Limited. Read the original for the full detail.